Personal Injury Lawyer
Personal Injury Attorney Firm Profile Attorney Profiles News and Events Contact Us
Information and Help

Wage and Overtime

Asbestos Lawyers

Personal Injury

First Levaquin Trial Completed

Lawyers for Plaintiffs and Defendants gave their closing arguments in the first Levaquin trial of more than 2,600 claims nationwide.
Levaquin is an antibiotic marketed by Johnson & Johnson. Plaintiffs argue that Johnson & Johnson should have warned consumers that Levaquin had an increased risk of tendon damage and rupture prior to the FDA's required "black box" warning added to the product label in 2008. The "black box" warning states that the risk of tendon ruptures is higher in patients older than 60, those taking steroids, and recipients of kidney, heart or lung transplants.
The Levaquin case being tried involves Plaintiff John Schedin, 82, who sued Johnson & Johnson in 2008 alleging he ruptured both of his Achilles tendons after taking Levaquin. Mr. Schedin argues that his doctor have prescribed another antibiotic had he known about the risks associated with Levaquin.
The lawsuit is part of the multidistrict litigation for all federal court Levaquin cases combined for trial in the United States District Court, District of Minnesota.

Million Dollar Advocates Forum

Public Citizen

Americas Top 100 Attorneys

Best D 2017

Attorney Web Design The information on this website is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. This information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship.